Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

abobotulinumtoxina

DYSPORT

abobotulinumtoxina (DYSPORT) is a synaptosomal-associated protein 25 inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 9
Pipeline programs 18
News articles 0
Drug details — abobotulinumtoxina
US status
approved
Class
—
Route
INJECTION
Patents
9
Programs
18
Data quality
0.84
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

abobotulinumtoxina (DYSPORT) is a synaptosomal-associated protein 25 inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN abobotulinumtoxina
Brand DYSPORT
Mechanism Synaptosomal-associated protein 25 inhibitor
Target Synaptosomal-associated protein 25
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Synaptosomal-associated protein 25 inhibitor

Primary target: Synaptosomal-associated protein 25

Approval history

Authority Status Date
FDA approved —

Pipeline programs

Search pipeline
  1. Botulinum Toxin type A (intradermal / submucosal injection at pain area) Phase 3 · First People's Hospital · Trigeminal Neuralgia
  2. Botulinum toxin type A Phase 3 · Ipsen · Low Back Pain
  3. Botulinum toxin type A Phase 3 · Hospital Authority · Obesity
  4. CLIN-52120-463 Phase 3 · Ipsen · Chronic migraine
  5. CLIN-52120-464 Phase 3 · Ipsen · Episodic Migraine
  6. botulinum toxin Type A Phase 3 · Allergan Pharmaceuticals International · Pediatrics
  7. BOTULINUM TOXIN , - Phase 2 · George Institute for · Myogenous temporomandibular disorders (TMDM)
  8. Botulinum Toxin Type B (Myobloc) Phase 2 · SUPERNUS PHARMACEUTICALS · Drooling

Related & competitor drugs

Browse all drugs
  1. daxibotulinumtoxina-lanm Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
  2. incobotulinumtoxina Synaptosomal-associated protein 25 inhibitor
  3. onabotulinumtoxina Synaptosomal-associated protein 25 inhibitor
  4. prabotulinumtoxina-xvfs Synaptosomal nerve-associated protein 25 (SNAP-25) proteolytic enzyme
  5. botulinum toxin type a Musculo-skeletal system (M03)
  6. letibotulinumtoxina-wlbg Synaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme

Related patents

Browse patents

  1. CA 3244873

    TRAITEMENT PRÉVENTIF DE LA MIGRAINE

    Expires Wed Sep 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2023077094

    TRAITEMENT D'UN TROUBLE DÉPRESSIF MAJEUR

    Expires Wed Apr 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 2023130736

    METHODS OF TREATING MIGRAINE

    Expires Wed Apr 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 2022380379

    PHARMACEUTICAL COMPOUNDS

    Expires Wed Nov 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 2021387969

    BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 AND/OR M4 RECEPTOR AGONISTS

    Expires Wed Dec 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. CA 3177686

    COMPOSITIONS COMPRENANT DE LA TROPOELASTINE RETICULEE A DE L'ACIDE HYALURONIQUE ET LEURS PROCEDES D'UTILISATION

    Expires Wed Nov 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. CA 3152006

    TROPOELASTINE DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DE LA CICATRISATION DE L'ACNE

    Expires Wed Feb 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2020012244

    TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AU MOYEN DE BRAZIKUMAB

    Expires Wed Jan 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2019016609

    TRAITEMENT DE LÉSIONS NON INFLAMMATOIRES

    Expires Wed Jan 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is abobotulinumtoxina?

abobotulinumtoxina (DYSPORT) is a synaptosomal-associated protein 25 inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for abobotulinumtoxina?

DYSPORT is a marketed brand name for abobotulinumtoxina. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of abobotulinumtoxina?

abobotulinumtoxina has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.